Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI vs. dye: can a computer match the gold standard for lynch syndrome screening?

NCT ID NCT05963191

First seen Sep 30, 2025 · Last updated Jun 17, 2026 · Updated 37 times

Summary

This study compares an artificial intelligence system (CAD-EYE) to the standard dye-spray method for finding precancerous polyps during colonoscopy in people with Lynch syndrome, a genetic condition that raises colorectal cancer risk. About 272 participants will be randomly assigned to one of the two methods. The goal is to see if the AI system is just as effective, which could make screening faster and easier.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYNCH SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Européen Georges-Pompidou HEGP

    RECRUITING

    Paris, 75015, France

    Contact

Conditions

The condition(s) this trial relates to.

Colorectal Neoplasms, Hereditary Nonpolyposis Lynch syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.